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Background
Infections, new onset diabetes mellitus (NODAT) and
rejection are frequent complications after renal transplan-
tation and may be related to innate immunity alterations.
We evaluate the relationship between serum mannose-
binding lectin (MBL) levels, chronic inflammation, infec-
tion, NODAT and subclinical rejection after renal
transplantation.
Patients and methods
Between March 2005 and October 2006 consecutive non-
diabetic renal transplant recipients were recruited. Serum
levels of MBL, soluble tumor necrosis factor receptor 2
(sTNFR2) and neutrophil gelatinase associated lipocalin
(NGAL) were determined before transplant and at 1 and 3
months. An oral glucose tolerance test was performed at 3
months. A surveillance 3-month renal biopsy was per-
formed in a subset of 60 patients with stable renal
function.
Results
A total of 125 patients were recruited and 111 had a func-
tioning graft at 3 months. MBL serum levels remained
unchanged following transplantation. Subjects with low
MBL (lower tertile) had higher pretransplant sTNFR2 (40
± 13 vs. 35 ± 11 ng/ml, p=0.05) and NGAL (638 ± 114 vs.
553 ± 185 ng/ml, p=0.03), an increased incidence of bac-
terial/fungal infection (p=0.021) and an increased preva-
lence of NODAT at 3 months (44.4 vs 22.6%, p=0.01).
Multivariate analysis confirmed that MBL was a risk factor
for NODAT (relative risk: 3.04, 95% confidence interval:
1.18-7.81; p=0.021) adjusting for age, pre-transplant
impaired fasting glucose and body mass index. Subclinical
rejection in the 3-month surveillance biopsy was observed
in 7 of 18 (38.9%) low MBL patients and in 3 of 42 (7.1%)
high MBL patients (p=0.005). Induction and maintenance
immunosuppression was not different in patients with low
and high MBL levels.
Conclusion
Low MBL serum levels in renal transplants are associated
with major outcome variable after renal transplantation
such as bacterial/fungal infections, NODAT and subclini-
cal rejection. These results suggest that alterations of the
innate immunity may play an important role in renal
transplantation.
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